Immunotherapy and Behavioural Immunity
Behavioural immunity that allow individual organisms to detect the possible presence of disease-causing parasites in their instant environment, and to seize in behaviours which prevent contact with those objects and individuals. The treatment using components of the immune system or antigens for immune disorders is called immunotherapy. Immunotherapy can activate or supress the immune system. Immunotherapies that activate the immune response are called activation immunotherapies. Immunotherapies that suppress the immune system are called suppression immunotherapies.
Immunotherapy is mainly used to treat:
- Allergies
- Autoimmune disorders
- Cancers
Related Conference of Immunotherapy and Behavioural Immunity
March 09-10, 2026
21th International Conference on Allergic Diseases and Clinical Immunology
Singapore City, Singapore
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Immunotherapy and Behavioural Immunity Conference Speakers
Recommended Sessions
- Immune Disorders
- Allergic Contact Dermatitis
- Allergic Rhinitis
- Allergy and Inflammation
- Anaphylaxis and Asthma
- Autoimmune Diseases
- Cancer Immunology
- Clinical Immunology
- Coronavirus and SARS-CoV-2
- Developmental Immunology
- Food Allergy and Drug Allergy
- Immune System and Allergic Reactions
- Immunopathology of COVID 19
- Immunotherapy and Behavioural Immunity
- Market and Future of Therapeutics
- Molecular Allergology and Allergy Diagnostics
- Neonatal and Pediatric Immunology
- Oral Allergy Syndrome
- Oral Immunotherapy and Allergen Immunotherapy
- Vaccination and Immunisation
- Veterinary Allergology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)